Mathias Wendt

Mathias Wendt

Auto-generated profile, based on publicly available information

Mathias Wendt

Department of Chemistry and Pharmaceutical Sciences VU University Amsterdam Amsterdam The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
PCPhilipp M. Cromm
Philipp M. Cromm
JSJochen Spiegel
Jochen Spiegel
PKPhilipp Küchler
Philipp Küchler
LDLaura Dietrich
Laura Dietrich
JKJulia Kriegesmann
Julia Kriegesmann
TGTom N Grossmann
Tom N Grossmann

29 March 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
MWMathias Wendt
Mathias Wendt
RBRosa Bellavita
Rosa Bellavita
AGAlan Gerber
Alan Gerber
NENina‐Louisa Efrém
Nina‐Louisa Efrém
TRThirza van Ramshorst
Thirza van Ramshorst
TGTom N Grossmann
Tom N Grossmann
Protein complexes are defined by the three‐dimensional structure of participating binding partners. Knowledge about these structures can facilitate the design of peptidomimetics which have been applied for example, as inhibitors of protein–protein interactions (PPIs). Even though β‐sheets participate widely in PPIs, they have only rarely served as the basis for peptidomimetic PPI inhibitors, in particular when addressing intracellular targets. Here, we present the structure‐based design of β‐sheet mimetics targeting the intracellular protein β‐catenin, a central component of the Wnt signaling pathway. Based on a protein binding partner of β‐catenin, a macrocyclic peptide was designed and its crystal structure in complex with β‐catenin obtained. Using this structure, we designed a library of bicyclic β‐sheet mimetics employing a late‐stage diversification strategy. Several mimetics were identified that compete with transcription factor binding to β‐catenin and inhibit Wnt signaling in cells. The presented design strategy can support the development of inhibitors for other β‐sheet‐mediated PPIs.

20 September 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
SJSadasivam Jeganathan
Sadasivam Jeganathan
MWMathias Wendt
Mathias Wendt
SKSebastian Kiehstaller
Sebastian Kiehstaller
DBDiego Brancaccio
Diego Brancaccio
AKArne Kuepper
Arne Kuepper
TGTom N Grossmann
Tom N Grossmann
Protein complex formation depends on the interplay between preorganization and flexibility of the binding epitopes involved. The design of epitope mimetics typically focuses on stabilizing a particular bioactive conformation, often without considering conformational dynamics, which limits the potential of peptidomimetics against challenging targets such as transcription factors. We developed a peptide‐derived inhibitor of the NF‐Y transcription factor by first constraining the conformation of an epitope through hydrocarbon stapling and then fine‐tuning its flexibility. In the initial set of constrained peptides, a single non‐interacting α‐methyl group was observed to have a detrimental effect on complex stability. Biophysical characterization revealed how this methyl group affects the conformation of the peptide in its bound state. Adaption of the methylation pattern resulted in a peptide that inhibits transcription factor assembly and subsequent recruitment to the target DNA.

29 March 2021 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
MWMathias Wendt
Mathias Wendt
RBRosa Bellavita
Rosa Bellavita
AGAlan Gerber
Alan Gerber
NENina‐Louisa Efrém
Nina‐Louisa Efrém
TRThirza van Ramshorst
Thirza van Ramshorst
TGTom N Grossmann
Tom N Grossmann
Protein complexes are defined by the three‐dimensional structure of participating binding partners. Knowledge about these structures can facilitate the design of peptidomimetics which have been applied for example, as inhibitors of protein–protein interactions (PPIs). Even though β‐sheets participate widely in PPIs, they have only rarely served as the basis for peptidomimetic PPI inhibitors, in particular when addressing intracellular targets. Here, we present the structure‐based design of β‐sheet mimetics targeting the intracellular protein β‐catenin, a central component of the Wnt signaling pathway. Based on a protein binding partner of β‐catenin, a macrocyclic peptide was designed and its crystal structure in complex with β‐catenin obtained. Using this structure, we designed a library of bicyclic β‐sheet mimetics employing a late‐stage diversification strategy. Several mimetics were identified that compete with transcription factor binding to β‐catenin and inhibit Wnt signaling in cells. The presented design strategy can support the development of inhibitors for other β‐sheet‐mediated PPIs.

19 April 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
MWMathias Wendt
Mathias Wendt
RBRosa Bellavita
Rosa Bellavita
AGAlan Gerber
Alan Gerber
NENina‐Louisa Efrém
Nina‐Louisa Efrém
TRThirza van Ramshorst
Thirza van Ramshorst
TGTom N Grossmann
Tom N Grossmann
Bicyclic peptidomimetics bind the transcriptional coactivator β‐catenin. A structure‐based design strategy has been applied to minimize a 52 amino acid binding motif into bicyclic 16‐mer β‐sheet mimetics. The biologically most active mimetic exhibits robust cellular uptake and inhibits Wnt signaling in a cell‐based assay, as reported by Tom N. Grossmann et al. in their Research Article (DOI: 10.1002/anie.202102082).

19 April 2021 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
MWMathias Wendt
Mathias Wendt
RBRosa Bellavita
Rosa Bellavita
AGAlan Gerber
Alan Gerber
NENina‐Louisa Efrém
Nina‐Louisa Efrém
TRThirza van Ramshorst
Thirza van Ramshorst
TGTom N Grossmann
Tom N Grossmann
Bizyklische Peptidomimetika binden den transkriptionellen Coaktivator β‐Catenin. Eine strukturbasierte Designstrategie wurde angewandt, um ein 52 Aminosäuren umfassendes Bindungsmotiv in bicyclische 16‐mere β‐Sheet‐Mimetika zu minimieren. Das biologisch aktivste Mimetikum zeigt eine robuste zelluläre Aufnahme und hemmt die Wnt‐Signaltransduktion in einem zellbasierten Assay, wie Tom N. Grossmann et al. in ihrem Forschungsartikel berichten (DOI: 10.1002/ange.202102082).